المؤلفون: López Muñoz AM; Medical Oncology, Hospital Universitario de Burgos, Avenida Islas Baleares S/N, 09006, Burgos, Spain. alopezmu@saludcastillayleon.es., González Flores E; Medical Oncology, Hospital Universitario Virgen de Las Nieves, Granada, Spain., Carral Maseda A; Medical Oncology, Hospital Universitario Lucus Augusti, Lugo, Spain., Pimentel Cáceres P; Medical Oncology, Hospital General Universitario Santa Lucia, Cartagena, Spain., Afonso Gómez R; Medical Oncology, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain., López López C; Medical Oncology, Hospital Universitario Marqués de Valdecilla IDIVAL, UNICAN, Santander, Spain., Jimeno Maté R; Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Reina Zoilo JJ; Medical Oncology, Hospital Universitario Virgen Macarena, Sevilla, Spain., Castañón López C; Medical Oncology, Complejo Asistencial Universitario de León, León, Spain., Salgado Fernández M; Medical Oncology, Complejo Hospitalario Universitario Ourense, Ourense, Spain., Aparicio Urtasun J; Medical Oncology, Hospital Universitario y Politécnico la Fe, Valencia, Spain., Asensio Martínez E; Medical Oncology, Hospital General Universitario de Elche, Elche, Spain., Martín Gómez T; Medical Oncology, Hospital Universitario Salamanca, Salamanca, Spain.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Aug 11. Date of Electronic Publication: 2024 Aug 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

المؤلفون: Gutiérrez Pérez C; Oncología Médica, Hospital Universitario de Burgos , España., Blanco Abad C; Oncología Médica, Hospital Universitario Miguel Servet, España., Hontoria Bautista G; Aparato Digestivo, Hospital Universitario de Burgos, España., Saiz López P; Anatomía Patológica, Hospital Universitario de Burgos, España., Rodríguez Ledesma I; Oncología Médica, Hospital Universitario de Burgos, España., Espinosa Cabria N; Oncología Médica, Hospital Universitario de Burgos , España., Ramos Reguera I; Oncología Médica, Hospital Universitario de Burgos, España., López Muñoz AM; Oncología Médica, Hospital Universitario de Burgos , España.

المصدر: Revista espanola de enfermedades digestivas [Rev Esp Enferm Dig] 2024 Apr; Vol. 116 (4), pp. 236-237.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Aran Ediciones Country of Publication: Spain NLM ID: 9007566 Publication Model: Print Cited Medium: Internet ISSN: 1130-0108 (Print) Linking ISSN: 11300108 NLM ISO Abbreviation: Rev Esp Enferm Dig Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/genetics , Proto-Oncogene Proteins p21(ras)*/genetics, Humans ; Mutation ; Retrospective Studies

المؤلفون: Gutiérrez Pérez C; Oncología Médica, Hospital Universitario de Burgos (HUBU), España., Rodríguez Ledesma I; Oncología Médica, Hospital universitario de Burgos (HUBU)., Blanco Abad C; Oncología Médica, Hospital Universitario de Burgos (HUBU), España., López Muñoz AM; Oncología Médica, Hospital Universitario de Burgos (HUBU), España., Chivato Martín-Falquina I; Aparato Digestivo, Hospital Universitario de Burgos (HUBU), España., Durán Domínguez M; Genética Molecular del Cáncer Hereditario, Instituto de Biología y Genética Molecular, España., Lastra Aras E; Oncología Médica, Hospital Universitario de Burgos (HUBU), España.

المصدر: Revista espanola de enfermedades digestivas [Rev Esp Enferm Dig] 2024 Apr; Vol. 116 (4), pp. 234-235.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Aran Ediciones Country of Publication: Spain NLM ID: 9007566 Publication Model: Print Cited Medium: Internet ISSN: 1130-0108 (Print) Linking ISSN: 11300108 NLM ISO Abbreviation: Rev Esp Enferm Dig Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms, Hereditary Nonpolyposis*/diagnosis , Colorectal Neoplasms, Hereditary Nonpolyposis*/genetics , Colorectal Neoplasms, Hereditary Nonpolyposis*/pathology , Colonic Neoplasms* , Adenocarcinoma*/pathology , Klatskin Tumor*/genetics , Neoplastic Syndromes, Hereditary* , Bile Duct Neoplasms*/genetics, Male ; Humans ; Aged ; MutS Homolog 2 Protein/genetics

المؤلفون: Contreras-Toledo D; Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Universidad de Oviedo, Oviedo, Spain. ct.debora@gmail.com., Jiménez-Fonseca P; Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Universidad de Oviedo, Oviedo, Spain., López CL; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Universidad de Cantabria (UNICAN), Santander, Spain., Montes AF; Department of Medical Oncology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain., López Muñoz AM; Department of Medical Oncology, Hospital Universitario de Burgos, Burgos, Spain., Vázquez Rivera F; Department of Medical Oncology, Hospital Universitario de Santiago, Santiago de Compostela, Spain., Alonso V; Department of Medical Oncology, Hospital Universitario Miguel Servet, IISA, Zaragoza, Spain., Alcaide J; Department of Medical Oncology, Hospital Costa del Sol, Marbella, Medical Oncology Intercenter Unit, Hospital Universitario Regional y Virgen de la Victoria, IBIMA, Málaga, Spain., Salvà F; Department of Medical Oncology, Hospital Universitario Vall D'Hebrón, Vall D´Hebrón Institute of Oncology (VHIO), Barcelona, Spain., Covela Rúa M; Department of Medical Oncology, Hospital Universitario Lucus Augusti, Lugo, Spain., Guillot M; Department of Medical Oncology, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Martín Carnicero A; Department of Medical Oncology, Hospital San Pedro, Logroño, Spain., Jimeno Mate R; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Cameselle García S; Department of Medical Oncology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain., Asensio Martínez E; Department of Medical Oncology, Hospital General Universitario de Elche, Elche, Spain., González Astorga B; Department of Medical Oncology, Hospital Universitario Clínico San Cecilio, Granada, Spain., Fernandez-Diaz AB; Department of Medical Oncology, Hospital General de Valencia, Valencia, Spain., González Villaroel P; Department of Medical Oncology, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain., Virgili Manrique AC; Department of Medical Oncology, Hospital Santa Creu i San Pau, Barcelona, Spain., Melián Sosa M; Department of Medical Oncology, Instituto Valenciano de Oncología (IVO), Valencia, Spain., Alonso B; Department of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain., Cousillas Castiñeiras A; Department of Medical Oncology, Complejo Hospitalario de Pontevedra, Pontevedra, Spain., Castañón López C; Department of Medical Oncology, Hospital Universitario de León, León, Spain., Aparicio J; Department of Medical Oncology, Hospital Universitario y Politécnico La Fe de Valencia, Valencia, Spain., Carmona-Bayonas A; Department of Medical Oncology, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB, Murcia, Spain. alberto.carmonabayonas@gmail.com.

المصدر: British journal of cancer [Br J Cancer] 2024 Mar; Vol. 130 (5), pp. 777-787. Date of Electronic Publication: 2024 Jan 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/pathology , Colonic Neoplasms*/genetics, Humans ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins p21(ras)/genetics ; Mutation ; Disease Progression

المؤلفون: Gutiérrez Pérez C; Oncología Médica, Hospital universitario de Burgos (HUBU), España., Rodríguez Ledesma I; Oncología Médica, Hospital universitario de Burgos (HUBU), España., Blanco Abad C; Oncología Médica, Hospital universitario de Burgos (HUBU), España., Catoya Villa JL; Oncología Médica, Hospital Universitario de Burgos (HUBU), España., Chivato Martín-Falquina I; Aparato Digestivo, Hospital Universitario de Burgos (HUBU), España., Cuenca Zarzuela A; Radiodiagnóstico, Hospital Universitario de Burgos (HUBU), España., López Muñoz AM; Oncología Médica, Hospital Universitario de Burgos (HUBU), España.

المصدر: Revista espanola de enfermedades digestivas [Rev Esp Enferm Dig] 2023 Oct; Vol. 115 (10), pp. 580-581.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Aran Ediciones Country of Publication: Spain NLM ID: 9007566 Publication Model: Print Cited Medium: Internet ISSN: 1130-0108 (Print) Linking ISSN: 11300108 NLM ISO Abbreviation: Rev Esp Enferm Dig Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/pathology , Adenocarcinoma*/genetics, Pregnancy ; Humans ; Female ; Adult ; Genetic Counseling ; Cesarean Section ; Germ-Line Mutation ; Genetic Predisposition to Disease

المؤلفون: González Astorga B; Hospital Universitario Clínico San Cecilio, Granada, Spain., Salvà Ballabrera F; Hospital Universitari Vall d'Hebron, Barcelona, Spain., Aranda Aguilar E; Hospital Universitario Reina Sofía, Córdoba, Spain., Élez Fernández E; Hospital Universitari Vall d'Hebron, Barcelona, Spain., García-Alfonso P; Hospital General Universitario Gregorio Marañón, Madrid, Spain., González Flores E; Hospital Universitario Virgen de Las Nieves, Granada, Spain., Vera García R; Complejo Hospitalario de Navarra, Navarra, Spain. ruth.vera.garcia@navarra.es., Fernández Montes A; Complexo Hospitalario de Ourense, Ourense, Spain., López Muñoz AM; Hospital Universitario de Burgos, Burgos, Spain., Salud Salvia A; Hospital Universitari Arnau de Vilanova, Lleida, Spain.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2021 Aug; Vol. 23 (8), pp. 1520-1528. Date of Electronic Publication: 2021 Feb 25.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Drug Substitution*, Angiogenesis Inhibitors/*therapeutic use , Colorectal Neoplasms/*drug therapy , Receptors, Vascular Endothelial Growth Factor/*therapeutic use , Recombinant Fusion Proteins/*therapeutic use, Age Factors ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bevacizumab/therapeutic use ; Camptothecin/analogs & derivatives ; Camptothecin/therapeutic use ; Clinical Trials, Phase III as Topic ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/pathology ; Fluorouracil/therapeutic use ; Genes, ras ; Humans ; Leucovorin/therapeutic use ; Liver Neoplasms/secondary ; Liver Neoplasms/surgery ; Lung Neoplasms/secondary ; Lung Neoplasms/surgery ; Mutation ; Neovascularization, Pathologic/drug therapy ; Organoplatinum Compounds/therapeutic use ; Proto-Oncogene Proteins B-raf/genetics ; Vascular Endothelial Growth Factor A/antagonists & inhibitors

SCR Protocol: Folfox protocol; IFL protocol

المؤلفون: Feliu J; Medical Oncology Department, IdiPAZ, CIBERONC, Cátedra UAM-AMGEN, Hospital Universitario La Paz, Paseo de la Castellana 261., 28046, Madrid, Spain. jaimefeliu@hotmail.com., Jorge Fernández M; Medical Oncology Department, Hospital Álvaro Cunqueiro, Vigo, Spain., Macarulla T; Medical Oncology Department, Vall d'Hebrón University Hospital and Vall d'Hebrón Institute of Oncology, IOB Quirón, Barcelona, Spain., Massuti B; Medical Oncology Department, Alicante University Hospital ISABIAL, Alicante, Spain., Albero A; Medical Oncology Department, Hospital Virgen Macarena, Sevilla, Spain., González González JF; Medical Oncology Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Quintero-Aldana G; Medical Oncology Department, Hospital Universitario Lucus Augusti (HULA), Lugo, Spain., Delgado-Mingorance JI; Medical Oncology Department, Hospital Universitario Badajoz, Badajoz, Spain., Fernández Montes A; Medical Oncology Department, Complexo Hospitalario Universitario de Ourense, Ourense, Spain., García Piernavieja C; Medical Oncology Department, Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Valladares-Ayerbes M; Medical Oncology Department, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocio, Sevilla, Spain., López Muñoz AM; Medical Oncology Department, Hospital Universitario de Burgos, Burgos, Spain., Mondéjar Solís R; Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain., Vicente P; Medical Oncology Department, Hospital Granollers, Granollers, Spain., Casado Gonzalez E; Medical Oncology Department, Hospital Althaia, Manresa, Spain., González Cebrián I; Digestive Cancer Department, San Cecilio Hospital, Granada, Spain., López-Vivanco G; Medical Oncology Department, Hospital Universitario Cruces, Barakaldo, Spain.

المصدر: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Apr; Vol. 87 (4), pp. 543-553. Date of Electronic Publication: 2021 Jan 15.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*drug therapy , Albumins/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Deoxycytidine/*analogs & derivatives , Paclitaxel/*administration & dosage , Pancreatic Neoplasms/*drug therapy, Adenocarcinoma/mortality ; Aged ; Albumins/adverse effects ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Female ; Humans ; Male ; Paclitaxel/adverse effects ; Pancreatic Neoplasms/mortality ; Quality of Life ; Gemcitabine

المؤلفون: Fernández Montes A; Medical Oncology Department, Complexo Hospitalario Universitario de Ourense, Ourense, Spain afm1003@hotmail.com., López López C; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Argilés Martínez G; Medical Oncology Department, Hospital Vall d'Hebrón, Barcelona, Spain., Páez López D; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., López Muñoz AM; Medical Oncology Department, Hospital Universitario de Burgos, Burgos, Spain., García Paredes B; Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain., Gutiérrez Abad D; Medical Oncology Department, Hospital de Fuenlabrada, Madrid, Spain., Castañón López C; Medical Oncology Department, Hospital Universitario de León, León, Spain., Jiménez Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Gallego Plazas J; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain., López Doldán MC; Medical Oncology Department, Complexo Hospitalario Universitario de Ourense, Ourense, Spain., Martínez de Castro E; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Sánchez Cánovas M; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Universidad de Murcia (UMU), Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain., Tobeña Puyal M; Medical Oncology Department, Hospital Vall d'Hebrón, Barcelona, Spain., Llorente Ayala B; Medical Oncology Department, Hospital Universitario de Burgos, Burgos, Spain., Juez Martel I; Medical Oncology Department, Hospital de Fuenlabrada, Madrid, Spain., López Flores M; Medical Oncology Department, Hospital Universitario de León, León, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Universidad de Murcia (UMU), Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.

المصدر: The oncologist [Oncologist] 2019 Aug; Vol. 24 (8), pp. e687-e695. Date of Electronic Publication: 2019 May 30.

نوع المنشور: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Nomograms*, Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Colorectal Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Camptothecin/administration & dosage ; Camptothecin/analogs & derivatives ; Colorectal Neoplasms/pathology ; Data Analysis ; Female ; Fluorouracil/administration & dosage ; Humans ; Irinotecan/administration & dosage ; Leucovorin/administration & dosage ; Male ; Middle Aged ; Prognosis ; Receptors, Vascular Endothelial Growth Factor/administration & dosage ; Recombinant Fusion Proteins/administration & dosage ; Retrospective Studies ; Survival Rate ; Treatment Outcome

SCR Protocol: IFL protocol